Roche | Roche’s virtual event on key neuromuscular data presented at the Muscular Dystrophy Association (MDA) scientific and clinical conference 2022

Roche’s virtual event on key neuromuscular data presented at the Muscular Dystrophy Association (MDA) scientific and clinical conference 2022

Agenda:

Welcome

Neuromuscular franchise strategy

Key Data at MDA 2022

Q&A

Bruno Eschli, Head of Investor Relations

Samir Megateli, Global Franchise Head, Neuromuscular Diseases, Global Product Strategy

Paulo Fontoura, Global Head of Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases Clinical Development

Please register to access the replay*

First Name

Last name

Corporate Email

Company Name

Confirm you are a human *

Roche has hosted a virtual event on Wednesday, 16 March 2022.

Investors

Downloads

PDF